Access Bio Signs Supply Contract for COVID-19 Antigen Test Kits Worth 10.8 Billion KRW
[Asia Economy Reporter Minji Lee] Access Bio announced on the 10th that it has signed a supply contract for COVID-19 antigen test kits with medical device distributor Intrivo Diagnostics, worth 10.844 billion KRW.
Hot Picks Today
"Suspicious Timing?"...Trump Traded Stocks After Praising Wartime Capabilities
- "Even If I Lose My Investment, the Government Will Cover It"... The Fund Attracting Retail Investors' Attention [Weekend Money]
- There Is a Distinct Age When Physical Abilities Decline Rapidly... From What Age Do Strength and Endurance Drop?
- "I Went to 10 Convenience Stores and Still Couldn't Buy It": The Bread Sensation That Sold 100 Million Units Already [The Way We Shop Now]
- "Contact Me First If Houses Are Built": Wealthy Clients Eyeing... Will Ultra-High-End Residences Worth 20 Billion Won Be Developed? [Real Estate AtoZ]
The contract amount corresponds to 25.18% of the consolidated sales at the end of last year. The contract period is from today until February 16 of next year.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
